In the beautiful setting of the College of Physicians of Philadelphia, Wistar friends attended this year’s Wistar Party, a celebration of Wistar science that has carried on for decades, and an opportunity for the Institute to express its gratitude…
PHILADELPHIA — (May 15, 2019) — Researchers at The Wistar Institute and the University of South Florida have advanced a novel compound that specifically targets the endoplasmic reticulum (ER) stress response that is frequently hyperactivated in ca…
Recently, Wistar had the great honor of bestowing its annual Women & Science’s Helen Dean King Award upon Dr. Mary-Claire King, one of the most esteemed and productive scientists of our time, in recognition of her seminal contributions to scie…
Along with warmer temperatures and the beautiful blossoming across the city, spring has become synonymous with the Philadelphia Science Festival, a staple and model for similar initiatives in other cities, that continues to grow each year. Establi…
Each year in early May, representatives from Wistar and fellow institutions who are part of the Pennsylvania Cancer Alliance engage legislators to reinforce the importance and impact of CURE funding. The Commonwealth Universal Research Enhancement…
PHILADELPHIA — (April 23, 2019) — After extensive peer review, The Wistar Institute’s Cancer Center has received an “exceptional” rating on its Cancer Center Support Grant (CCSG) application from the National Cancer Institute (NCI) for the second …
In a study published online in Nature, the lab of Dmitry I. Gabrilovich, M.D., Ph.D., Christopher M. Davis Professor and leader of the Immunology, Microenvironment and Metastasis Program, identified a critical step that happens when parts of the i…
For two decades, Wistar’s Biomedical Technician Training (BTT) pre-apprenticeship program has injected biomedical talent into the region’s life sciences workforce by ushering class after class of promising Community College of Philadelphia (CCP) s…
PHILADELPHIA — (April 18, 2019) — Wistar scientists have developed a novel synthetic DNA approach for patient-specific production of cancer-targeting molecules called bispecific T cell engagers. DNA-encoded bispecific T cell engagers (dBiTEs) desi…
PHILADELPHIA — (April 17, 2019) — Wistar scientists have identified a critical regulator of the function of myeloid derived suppressive cells (MDSCs), opening new opportunities for specific therapeutic targeting of these cells to inhibit tumor gro…
